N@N

Alex Thompson Initiated (ASND) at Strong Buy and Held Target at $200 on, May 31st, 2024

Alex Thompson of Stifel, Initiated "Ascendis Pharma A/S" (ASND) at Strong Buy and Held Target at $200 on, May 31st, 2024.

Alex has made no other calls on ASND in the last 4 months.

There are 6 other peers that have a rating on ASND. Out of the 6 peers that are also analyzing ASND, 1 agrees with Alex's Rating of Hold. Following is the relevant analyst calls for the last 4 months

---

• Vikram Purohit of "Morgan Stanley" Maintained at Hold with Increased Target to $140 on, Thursday, May 16th, 2024

These are the ratings of the 5 analyists that currently disagree with Alex

---

• Li Watsek of "Cantor Fitzgerald" Reiterated at Buy and Held Target at $173 on, Wednesday, May 15th, 2024
• Derek Archila of "Wells Fargo" Maintained at Buy with Increased Target to $262 on, Friday, May 3rd, 2024
• Jessica Fye of "JP Morgan" Maintained at Buy with Increased Target to $170 on, Friday, May 3rd, 2024
• Andreas Argyrides of "Wedbush" Maintained at Buy with Increased Target to $225 on, Thursday, February 8th, 2024
• David Lebowitz of "Citigroup" Maintained at Strong Buy with Increased Target to $182 on, Thursday, February 8th, 2024

Contributing Sources

---